“…However, for those research applications in which it could be advantageous or informative to have control over dose delivery or high-resolution data on the distribution of genomic and phenotypic outcomes with relatively few cells, we ask those readers to consider the following ideas for future needs and technological advancements that would allow precision manipulation to be coupled with precision measurement: - Deliver “treatment” and “control” conditions side by side to cells in the same environment (Figure A).
- Technology requirement: The ability to identify, index, and sort cells, so that each condition delivered to cells is distinguishable and can be observed or assayed separately.
- Possible innovations on existing technologies: CRISPR/Cas9 optogenetic variants (recently reviewed in refs and ) coupled with photostimulation instrumentation that delivers a controlled illumination pattern to part of a field of view; , direct microinjection. ,
- Reproducible controlled delivery of a solution to a single cell, and the capability to shift the dose delivered in controlled increments (Figure B).
- Technology requirement: Ability to control and produce parameters reproducibly (i.e., for electroporation, N pulses, voltage, pulse duration; for injection, dimensions of microinjection needle, aperture area, pressure, and duration).
- Possible innovations in existing technologies: Microinjection with pressure and duration control to deliver editing reagents, electroporation coupled with single-cell electroporation in microchannels, nanostraws, − electrowetting, injections using microfluidically formed droplets, and injections with a cantilever connected to a microfluidic reservoir. ,
- Measure the volume of the editing solution and the number of editing molecules delivered into a single cell (Figure C).
- Technology requirement: The ability to quantify the volume of a solution and the quantity of biomolecules delivered to a cell. If using a visual readout such as fluorescent reporters, this may require a calibration standard to convert a measured fluorescence intensity into known quantities of volumes and editing biomolecules delivered to the cell.
- Possible innovations of existing technologies: Microfluidic flow measurement analysis, calibration slide with photostable fluorescent material, microspheres with assigned equivalent reference fluorophore units (ERFs), , and adoption of ASTM F3294-18 that provides a guide of standards for using microscopy-based methods to make quantitative fluorescence intensity measurements in cell-based assays
…”